SOCS2 and metastatic malignant neoplasm in the lymph nodes: Further analysis indicated that the expression of SOCS2 negatively correlated with clinical stage (p = 0.045) and lymph node metastasis (p = 0.013) especially in patients with lung adenocarcinomas (Supplementary Table S1).